LGND: Summary for Ligand Pharmaceuticals Incorpor - Yahoo! Canada Finance

	Sign In [New User? Sign Up]	Finance Home \|Help

Wednesday, February 10, 2010, 6:17am EST - Canadian Markets open in 3 hours and 13 minutes.

To create a watchlist or portfolio of shares, Sign-in or Register

Ligand Pharmaceuticals Inc. (LGND)

On Feb 9: 1.66 USD 0.00 (0.00%)

MORE ON LGND

Quotes

Summary

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

Ligand Pharmaceuticals Incorpor (NGM:LGND) Delayed quote data

Last Trade:	1.66 USD
Trade Time:	Feb 9
Change:	0.00 (0.00%)
Prev Close:	1.66
Open:	N/A
Bid:	1.41 x 200
Ask:	2.11 x 2000
1y Target Est:	5.00

Day's Range:	N/A - N/A
52wk Range:	1.55 - 3.21
Volume:	0
Avg Vol (3m):	594,203
Market Cap:	187.61M
P/E (ttm):	N/A
EPS (ttm):	-0.76
Div & Yield:	N/A (N/A%)

1d 5d 3m 6m 1y 2y 5y max

Add LGND to Portfolio

Download Data

HEADLINES

•	Earnings roundup: Molson Coors, IAC
	AP (Tue 2:15pm)

•	Ligand Pharmaceuticals Incorporated Q4 2009 Earnings Call Transcript
	at Seeking Alpha (Tue 1:20pm)

•	Ligand posts 4Q profit as charge comes off books
	AP (Tue 1:11pm)

•	Ligand Announces Fourth Quarter and Full Year 2009 Consolidated Financial Results
	Business Wire (Tue 8:16am)

•	LIGAND PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements an
	EDGAR Online (Tue 8:02am)

•	LIGAND PHARMACEUTICALS INC Files SEC form 8-K, Triggering Events That Accelerate or Increase a Direct Financial Oblig
	EDGAR Online (Mon, Feb 8)

•	Get Ready for the Bounce
	at Motley Fool (Mon, Feb 8)

•	Ligand to Report Fourth Quarter Results on February 9th
	Business Wire (Mon, Feb 1)

•	LIGAND PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Completion of Acquisition
	EDGAR Online (Thu, Jan 28)

•	Ligand Completes Acquisition of Metabasis
	Business Wire (Thu, Jan 28)

More Headlines for LGND...

ANALYST

EPS Est (next year) (Dec-09) :	-0.10
EPS Est (in 2 years) (Dec-10) :	-0.06
Avg Rec (current)*:	3.0
PEG Ratio:	N/A

* (Strong Buy) 1.0 - 5.0 (Strong Sell)

Analyst Opinion - Estimates

BUSINESS SUMMARY

Ligand Pharmaceuticals Incorporated, a biotechnology company, focuses on the discovery and development of pharmaceuticals for the critical unmet medical needs in the United States.

Full Company Profile

Add to Portfolio

Email to a Friend

•